Hyundai Everdigm Corp. (KOSDAQ:041440)
South Korea · Delayed Price · Currency is KRW 8,850.00
-130.00 (-1.45%)
At close: Feb 20, 2026
Hyundai Everdigm Market Cap
Hyundai Everdigm has a market cap or net worth of 157.9 billion as of February 20, 2026. Its market cap has decreased by -2.75% in one year.
Market Cap
157.90B
Enterprise Value
214.56B
Revenue
365.16B
Ranking
n/a
PE Ratio
17.04
Stock Price
8,850.00
Market Cap Chart
Since March 1, 2004, Hyundai Everdigm's market cap has increased from 36.49B to 157.90B, an increase of 332.75%. That is a compound annual growth rate of 6.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 157.90B | 7.66% |
| Dec 30, 2025 | 146.66B | -0.36% |
| Dec 30, 2024 | 147.19B | 29.92% |
| Dec 28, 2023 | 113.29B | -22.75% |
| Dec 29, 2022 | 146.66B | 58.08% |
| Dec 30, 2021 | 92.78B | 20.93% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| OPTUS Pharmaceutical | 159.00B |
| Kumyang Green Power | 158.92B |
| DASAN Networks | 158.27B |
| KUKJEON PHARMACEUTICAL | 158.06B |
| Wonil T&I | 157.82B |
| LB Investment | 157.75B |
| KX Innovation | 157.57B |
| OptiCore | 157.36B |